KD-PACE chemotherapy regimen as a salvage therapy for aggressive, refractory multiple myeloma
Maciej Dubaj(Medical University of Lublin), Marek Hus(Medical University of Lublin), Olga Czabak, Dorota Hawrylecka, Karol Bigosiński(1 Military Clinical Hospital with Outpatient Clinic), Aneta Szudy‐Szczyrek(Medical University of Lublin)
Cited by 0
Related Papers
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2024|162
Therapy‐related peripheral neuropathy in multiple myeloma patients
|Hematological Oncology|2014|70